Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP TMS SA : EDAP Reports Q4 and Full Year 2018 Results
Reports record revenues for the fifth consecutive year Record fiscal year 2018 revenues of €39.2 million Q4 2018 HIFU net sales increased 79% year-over-year Profitable and cash flow positive during the fourth quarter of 2018 Completed first U.S. sale of Focal One at the end of 2018 Ended the year
View HTML
Toggle Summary EDAP TMS SA : University of Chicago Medicine Becomes First Hospital in the Midwest to Acquire Breakthrough Focal One® HIFU Advanced Robotic Technology for Prostate Cancer Treatment
Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence LYON, France - April 1, 2019 - EDAP TMS SA (Nasdaq: EDAP) , the global leader in therapeutic ultrasound, today announced that
View HTML
Toggle Summary EDAP TMS SA : EDAP TMS SA to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Monday, April 1, 2019
Company to host conference call and webcast on Tuesday, April 2 at 8:30am EDT LYON , France, March 21, 2019  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the fourth quarter and year ended December 31,
View HTML
Toggle Summary EDAP TMS SA : HIFU Pioneer Houston Methodist Hospital Acquires EDAP's Next Generation Focal One HIFU System
    Houston Methodist's Upgrade from Ablatherm to Focal One Reinforces EDAP's Position as a Leading HIFU Innovator LYON, France , March 4, 2019 -- EDAP TMS SA (Nasdaq: EDAP) -- Houston Methodist Hospital , one of the first hospitals in the U.S. to offer Ablatherm® Robotic High Intensity Focused
View HTML
Toggle Summary EDAP TMS SA : UCI Health Medical Center Becomes First in the U.S. to Treat Patients Using EDAP's Breakthrough Focal One® HIFU Technology
UC I Health , one of the three US medical centers to acquire EDAP's Focal One device, is a recognized leader in prostate cancer diagnosis and treatment utilizing robot-assisted and minimally invasive technologies LYON, France , February 5 , 2019 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the
View HTML
Toggle Summary EDAP TMS SA : EDAP Announces the Purchase of Focal One® HIFU by Maimonides Medical Center, Brooklyn, NY
Maimonides Medical Center to Become the First Hospital on the East Coast of the US to Acquire Focal One Technology and Offer the World's Most Advanced HIFU Prostate Treatment LYON, France - January 18, 2019 - EDAP TMS SA (Nasdaq: EDAP) today announced that Brooklyn, New York's Maimonides Medical
View HTML
Toggle Summary EDAP TMS SA : EDAP Announces Sales of Two Additional Focal One® Devices in Brazil
Hospital 9 de Julho and Hospital Moriah join growing roster of highly-regarded hospitals in Brazil offering Focal One LYON, France , January 14, 2019 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today that the Company has completed sales of
View HTML
Toggle Summary EDAP TMS SA : John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One® Technology for Prostate Tissue Ablation
    Focal One System Enhances Precision Tissue Ablation, Reduces Side Effects for Prostate Cancer Patients LYON, France -- January 3, 2019 - EDAP TMS SA (Nasdaq: EDAP) today announced that the John Wayne Cancer Institute (JWCI) at the Providence Saint John's Health Center in Santa Monica, CA is the
View HTML
Toggle Summary EDAP TMS SA : EDAP Announces Expiration of Second and Final Tranche of Outstanding Warrants
Warrants for 1.5 Million Ordinary Shares in the Form of American Depository Shares Expired on November 29, 2018 Capital Structure Now Comprised Exclusively of Common Stock LYON, France , November 29, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound,
View HTML
Toggle Summary EDAP TMS SA : EDAP to Present a Corporate Update at the 30th Annual Piper Jaffray Conference
LYON , France, November 20, 2018  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference , taking place November 27-29, 2018 in New York City .
View HTML